Abbott Laboratories announced Thursday its over-the-counter continuous glucose monitor Lingo is available in the U.S. starting at $49. These devices, called continuous glucose monitors, are small sensors that stick through the skin to measure real-time glucose levels. Continuous glucose monitors have served as tools for patients with diabetes, but Lingo is not intended for diabetes management. The company released its over-the-counter continuous glucose monitor geared toward this demographic in late August. The U.S. Food and Drug Administration approved Dexcom's Stelo in March, and it cleared two over-the-counter continuous glucose monitoring systems from Abbott in June.

---

Persons: Lingo, it's, Abbott, That's, Ben Fohner, Abbott's, Olivier Ropars, Ropars, Dexcom's Organizations: Abbott, CNBC, U.S . Food, Drug Administration, Dexcom's Stelo, Libre, Libre Rio Locations: U.S